nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—asthma—chronic obstructive pulmonary disease	0.506	1	CtDrD
Zileuton—CYP1A2—chronic obstructive pulmonary disease	0.174	1	CbGaD
Zileuton—ALOX5—Montelukast—chronic obstructive pulmonary disease	0.115	0.502	CbGbCtD
Zileuton—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0259	0.113	CbGbCtD
Zileuton—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0138	0.06	CbGbCtD
Zileuton—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0138	0.06	CbGbCtD
Zileuton—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.013	0.0566	CbGbCtD
Zileuton—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0106	0.046	CbGbCtD
Zileuton—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0104	0.0454	CbGbCtD
Zileuton—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00714	0.0311	CbGbCtD
Zileuton—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00681	0.0296	CbGbCtD
Zileuton—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00607	0.0264	CbGbCtD
Zileuton—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00356	0.0155	CbGbCtD
Zileuton—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00336	0.0146	CbGbCtD
Zileuton—LTB4R—respiratory system—chronic obstructive pulmonary disease	0.00159	0.159	CbGeAlD
Zileuton—Traumatic liver injury—Montelukast—chronic obstructive pulmonary disease	0.00136	0.0302	CcSEcCtD
Zileuton—LTB4R—bronchus—chronic obstructive pulmonary disease	0.00131	0.131	CbGeAlD
Zileuton—LTB4R—trachea—chronic obstructive pulmonary disease	0.00118	0.118	CbGeAlD
Zileuton—Pharyngolaryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.000946	0.0211	CcSEcCtD
Zileuton—Laryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.000937	0.0209	CcSEcCtD
Zileuton—LTB4R—lung—chronic obstructive pulmonary disease	0.000847	0.0846	CbGeAlD
Zileuton—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.000741	0.0165	CcSEcCtD
Zileuton—ALOX5—respiratory system—chronic obstructive pulmonary disease	0.000703	0.0702	CbGeAlD
Zileuton—EPHX2—lung—chronic obstructive pulmonary disease	0.000623	0.0622	CbGeAlD
Zileuton—ALOX5—connective tissue—chronic obstructive pulmonary disease	0.000619	0.0618	CbGeAlD
Zileuton—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.0006	0.0134	CcSEcCtD
Zileuton—ALOX5—bronchus—chronic obstructive pulmonary disease	0.000578	0.0578	CbGeAlD
Zileuton—ALOX5—smooth muscle tissue—chronic obstructive pulmonary disease	0.000566	0.0566	CbGeAlD
Zileuton—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.000552	0.0123	CcSEcCtD
Zileuton—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.000533	0.0119	CcSEcCtD
Zileuton—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.000449	0.00999	CcSEcCtD
Zileuton—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000436	0.0097	CcSEcCtD
Zileuton—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00962	CcSEcCtD
Zileuton—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00962	CcSEcCtD
Zileuton—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000431	0.0096	CcSEcCtD
Zileuton—Hypertonia—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00949	CcSEcCtD
Zileuton—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00942	CcSEcCtD
Zileuton—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00922	CcSEcCtD
Zileuton—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.000412	0.00917	CcSEcCtD
Zileuton—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.0004	0.00891	CcSEcCtD
Zileuton—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000378	0.00841	CcSEcCtD
Zileuton—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000373	0.00831	CcSEcCtD
Zileuton—ALOX5—lung—chronic obstructive pulmonary disease	0.000373	0.0373	CbGeAlD
Zileuton—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000372	0.00829	CcSEcCtD
Zileuton—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.00773	CcSEcCtD
Zileuton—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00746	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00033	0.00735	CcSEcCtD
Zileuton—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000328	0.00729	CcSEcCtD
Zileuton—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000326	0.0325	CbGeAlD
Zileuton—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00718	CcSEcCtD
Zileuton—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000319	0.0071	CcSEcCtD
Zileuton—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000313	0.00696	CcSEcCtD
Zileuton—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00031	0.0069	CcSEcCtD
Zileuton—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00669	CcSEcCtD
Zileuton—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00669	CcSEcCtD
Zileuton—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000299	0.00665	CcSEcCtD
Zileuton—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000294	0.00655	CcSEcCtD
Zileuton—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00647	CcSEcCtD
Zileuton—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000288	0.00641	CcSEcCtD
Zileuton—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.0064	CcSEcCtD
Zileuton—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00632	CcSEcCtD
Zileuton—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000282	0.0282	CbGeAlD
Zileuton—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00624	CcSEcCtD
Zileuton—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00624	CcSEcCtD
Zileuton—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00624	CcSEcCtD
Zileuton—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00624	CcSEcCtD
Zileuton—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00613	CcSEcCtD
Zileuton—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00611	CcSEcCtD
Zileuton—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00602	CcSEcCtD
Zileuton—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00602	CcSEcCtD
Zileuton—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000267	0.00594	CcSEcCtD
Zileuton—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00591	CcSEcCtD
Zileuton—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000265	0.0059	CcSEcCtD
Zileuton—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00589	CcSEcCtD
Zileuton—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00589	CcSEcCtD
Zileuton—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00568	CcSEcCtD
Zileuton—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00564	CcSEcCtD
Zileuton—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000248	0.0248	CbGeAlD
Zileuton—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000248	0.00552	CcSEcCtD
Zileuton—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00024	0.00533	CcSEcCtD
Zileuton—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00529	CcSEcCtD
Zileuton—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00529	CcSEcCtD
Zileuton—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00529	CcSEcCtD
Zileuton—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00023	0.00513	CcSEcCtD
Zileuton—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000228	0.00508	CcSEcCtD
Zileuton—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000228	0.00508	CcSEcCtD
Zileuton—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000227	0.0227	CbGeAlD
Zileuton—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000227	0.00505	CcSEcCtD
Zileuton—Tension—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00492	CcSEcCtD
Zileuton—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00492	CcSEcCtD
Zileuton—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00487	CcSEcCtD
Zileuton—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00487	CcSEcCtD
Zileuton—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00486	CcSEcCtD
Zileuton—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000215	0.00479	CcSEcCtD
Zileuton—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.00473	CcSEcCtD
Zileuton—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00467	CcSEcCtD
Zileuton—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00465	CcSEcCtD
Zileuton—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00465	CcSEcCtD
Zileuton—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00465	CcSEcCtD
Zileuton—PTGS1—trachea—chronic obstructive pulmonary disease	0.000208	0.0208	CbGeAlD
Zileuton—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00462	CcSEcCtD
Zileuton—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.0046	CcSEcCtD
Zileuton—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000206	0.00459	CcSEcCtD
Zileuton—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00452	CcSEcCtD
Zileuton—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00452	CcSEcCtD
Zileuton—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00446	CcSEcCtD
Zileuton—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00439	CcSEcCtD
Zileuton—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00438	CcSEcCtD
Zileuton—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00434	CcSEcCtD
Zileuton—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00427	CcSEcCtD
Zileuton—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000191	0.00425	CcSEcCtD
Zileuton—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00422	CcSEcCtD
Zileuton—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00422	CcSEcCtD
Zileuton—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00418	CcSEcCtD
Zileuton—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00418	CcSEcCtD
Zileuton—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00403	CcSEcCtD
Zileuton—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00403	CcSEcCtD
Zileuton—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00403	CcSEcCtD
Zileuton—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.00403	CcSEcCtD
Zileuton—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00398	CcSEcCtD
Zileuton—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.00396	CcSEcCtD
Zileuton—CYP1A2—lung—chronic obstructive pulmonary disease	0.000173	0.0173	CbGeAlD
Zileuton—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000171	0.0038	CcSEcCtD
Zileuton—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00374	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00373	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00373	CcSEcCtD
Zileuton—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000166	0.0037	CcSEcCtD
Zileuton—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.0037	CcSEcCtD
Zileuton—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00368	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00365	CcSEcCtD
Zileuton—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00364	CcSEcCtD
Zileuton—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00364	CcSEcCtD
Zileuton—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00363	CcSEcCtD
Zileuton—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.0036	CcSEcCtD
Zileuton—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.0036	CcSEcCtD
Zileuton—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00359	CcSEcCtD
Zileuton—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00356	CcSEcCtD
Zileuton—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00356	CcSEcCtD
Zileuton—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00353	CcSEcCtD
Zileuton—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00353	CcSEcCtD
Zileuton—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00353	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00352	CcSEcCtD
Zileuton—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.0035	CcSEcCtD
Zileuton—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.0035	CcSEcCtD
Zileuton—Pain—Formoterol—chronic obstructive pulmonary disease	0.000157	0.0035	CcSEcCtD
Zileuton—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000157	0.0035	CcSEcCtD
Zileuton—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.0035	CcSEcCtD
Zileuton—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00346	CcSEcCtD
Zileuton—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00344	CcSEcCtD
Zileuton—Pain—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00343	CcSEcCtD
Zileuton—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.00342	CcSEcCtD
Zileuton—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.0034	CcSEcCtD
Zileuton—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00339	CcSEcCtD
Zileuton—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00339	CcSEcCtD
Zileuton—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00338	CcSEcCtD
Zileuton—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00337	CcSEcCtD
Zileuton—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00337	CcSEcCtD
Zileuton—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00337	CcSEcCtD
Zileuton—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00335	CcSEcCtD
Zileuton—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00334	CcSEcCtD
Zileuton—PTGS1—lung—chronic obstructive pulmonary disease	0.00015	0.015	CbGeAlD
Zileuton—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.0033	CcSEcCtD
Zileuton—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.0033	CcSEcCtD
Zileuton—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00325	CcSEcCtD
Zileuton—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00325	CcSEcCtD
Zileuton—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00324	CcSEcCtD
Zileuton—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00324	CcSEcCtD
Zileuton—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.00322	CcSEcCtD
Zileuton—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.0032	CcSEcCtD
Zileuton—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00319	CcSEcCtD
Zileuton—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.00319	CcSEcCtD
Zileuton—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00318	CcSEcCtD
Zileuton—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00318	CcSEcCtD
Zileuton—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.00318	CcSEcCtD
Zileuton—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00317	CcSEcCtD
Zileuton—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00307	CcSEcCtD
Zileuton—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00305	CcSEcCtD
Zileuton—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00302	CcSEcCtD
Zileuton—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00302	CcSEcCtD
Zileuton—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.00301	CcSEcCtD
Zileuton—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00295	CcSEcCtD
Zileuton—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.0029	CcSEcCtD
Zileuton—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00013	0.0029	CcSEcCtD
Zileuton—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00285	CcSEcCtD
Zileuton—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00284	CcSEcCtD
Zileuton—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.0028	CcSEcCtD
Zileuton—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000126	0.0028	CcSEcCtD
Zileuton—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00274	CcSEcCtD
Zileuton—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00273	CcSEcCtD
Zileuton—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00271	CcSEcCtD
Zileuton—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00271	CcSEcCtD
Zileuton—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00265	CcSEcCtD
Zileuton—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00264	CcSEcCtD
Zileuton—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000117	0.0026	CcSEcCtD
Zileuton—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.0026	CcSEcCtD
Zileuton—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00258	CcSEcCtD
Zileuton—Rash—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00258	CcSEcCtD
Zileuton—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00258	CcSEcCtD
Zileuton—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00258	CcSEcCtD
Zileuton—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00256	CcSEcCtD
Zileuton—Headache—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00256	CcSEcCtD
Zileuton—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00256	CcSEcCtD
Zileuton—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000115	0.00255	CcSEcCtD
Zileuton—Rash—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00253	CcSEcCtD
Zileuton—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00253	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00252	CcSEcCtD
Zileuton—Headache—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00251	CcSEcCtD
Zileuton—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00246	CcSEcCtD
Zileuton—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00245	CcSEcCtD
Zileuton—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00244	CcSEcCtD
Zileuton—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00243	CcSEcCtD
Zileuton—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000109	0.00243	CcSEcCtD
Zileuton—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.00243	CcSEcCtD
Zileuton—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00242	CcSEcCtD
Zileuton—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000107	0.00238	CcSEcCtD
Zileuton—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.0023	CcSEcCtD
Zileuton—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00228	CcSEcCtD
Zileuton—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.01e-05	0.002	CcSEcCtD
Zileuton—Pain—Prednisolone—chronic obstructive pulmonary disease	8.52e-05	0.0019	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.00183	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.21e-05	0.00183	CcSEcCtD
Zileuton—Malaise—Prednisone—chronic obstructive pulmonary disease	8e-05	0.00178	CcSEcCtD
Zileuton—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.91e-05	0.00176	CcSEcCtD
Zileuton—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.00168	CcSEcCtD
Zileuton—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.00168	CcSEcCtD
Zileuton—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.00166	CcSEcCtD
Zileuton—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.34e-05	0.00163	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.05e-05	0.00196	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.97e-05	0.00194	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	6.93e-05	0.00193	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	6.75e-05	0.00188	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	6.7e-05	0.00186	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	6.66e-05	0.00185	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.00147	CcSEcCtD
Zileuton—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.59e-05	0.00147	CcSEcCtD
Zileuton—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.56e-05	0.00182	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	6.55e-05	0.00182	CbGpPWpGaD
Zileuton—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.00146	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.45e-05	0.00179	CbGpPWpGaD
Zileuton—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.41e-05	0.00178	CbGpPWpGaD
Zileuton—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.00142	CcSEcCtD
Zileuton—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00177	CbGpPWpGaD
Zileuton—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.33e-05	0.00176	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.32e-05	0.00176	CbGpPWpGaD
Zileuton—Rash—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.0014	CcSEcCtD
Zileuton—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.27e-05	0.0014	CcSEcCtD
Zileuton—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.25e-05	0.00174	CbGpPWpGaD
Zileuton—Headache—Prednisolone—chronic obstructive pulmonary disease	6.24e-05	0.00139	CcSEcCtD
Zileuton—Constipation—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.00138	CcSEcCtD
Zileuton—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	6.13e-05	0.0017	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.08e-05	0.00169	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	6.04e-05	0.00168	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.04e-05	0.00168	CbGpPWpGaD
Zileuton—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.00133	CcSEcCtD
Zileuton—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.92e-05	0.00132	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	5.79e-05	0.00161	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.78e-05	0.00161	CbGpPWpGaD
Zileuton—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.75e-05	0.00128	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.00127	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.67e-05	0.00158	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.66e-05	0.00157	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	5.63e-05	0.00157	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.61e-05	0.00156	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.58e-05	0.00155	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.45e-05	0.00152	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.4e-05	0.0015	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.39e-05	0.0015	CbGpPWpGaD
Zileuton—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.38e-05	0.00149	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.35e-05	0.00149	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.00119	CcSEcCtD
Zileuton—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.3e-05	0.00147	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.25e-05	0.00146	CbGpPWpGaD
Zileuton—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	5.23e-05	0.00145	CbGpPWpGaD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.2e-05	0.00145	CbGpPWpGaD
Zileuton—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.00114	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.05e-05	0.0014	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.04e-05	0.0014	CbGpPWpGaD
Zileuton—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.0011	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.94e-05	0.00137	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.00137	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.00137	CbGpPWpGaD
Zileuton—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.00137	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.88e-05	0.00136	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.87e-05	0.00135	CbGpPWpGaD
Zileuton—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	4.86e-05	0.00135	CbGpPWpGaD
Zileuton—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	4.8e-05	0.00133	CbGpPWpGaD
Zileuton—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.00107	CcSEcCtD
Zileuton—ALOX5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.69e-05	0.0013	CbGpPWpGaD
Zileuton—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.0013	CbGpPWpGaD
Zileuton—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.66e-05	0.0013	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.65e-05	0.00129	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.00128	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	4.61e-05	0.00128	CbGpPWpGaD
Zileuton—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.00102	CcSEcCtD
Zileuton—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.6e-05	0.00128	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.58e-05	0.00127	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GC—chronic obstructive pulmonary disease	4.56e-05	0.00127	CbGpPWpGaD
Zileuton—Rash—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.00102	CcSEcCtD
Zileuton—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.00101	CcSEcCtD
Zileuton—Headache—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.00101	CcSEcCtD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	4.52e-05	0.00126	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.5e-05	0.00125	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.48e-05	0.00125	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	4.44e-05	0.00124	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.44e-05	0.00124	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	4.44e-05	0.00123	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.43e-05	0.00123	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.38e-05	0.00122	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.33e-05	0.0012	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.31e-05	0.0012	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.31e-05	0.0012	CbGpPWpGaD
Zileuton—Nausea—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.000957	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.29e-05	0.00119	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.24e-05	0.00118	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.23e-05	0.00118	CbGpPWpGaD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.18e-05	0.00116	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.13e-05	0.00115	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.09e-05	0.00114	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.04e-05	0.00112	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.03e-05	0.00112	CbGpPWpGaD
Zileuton—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.98e-05	0.00111	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.94e-05	0.00109	CbGpPWpGaD
Zileuton—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.93e-05	0.00109	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.00106	CbGpPWpGaD
Zileuton—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	3.8e-05	0.00106	CbGpPWpGaD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.00105	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.00105	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.73e-05	0.00104	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.61e-05	0.001	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.58e-05	0.000994	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.43e-05	0.000953	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.38e-05	0.00094	CbGpPWpGaD
Zileuton—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	3.37e-05	0.000936	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.32e-05	0.000924	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.29e-05	0.000913	CbGpPWpGaD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.23e-05	0.000898	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.15e-05	0.000876	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.11e-05	0.000864	CbGpPWpGaD
Zileuton—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.09e-05	0.00086	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.000854	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	3.07e-05	0.000854	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.06e-05	0.000852	CbGpPWpGaD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.03e-05	0.000843	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.93e-05	0.000814	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.86e-05	0.000794	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.84e-05	0.00079	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.81e-05	0.00078	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.76e-05	0.000768	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	2.73e-05	0.000758	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.72e-05	0.000757	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.71e-05	0.000752	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.7e-05	0.000751	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.69e-05	0.000747	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.62e-05	0.000728	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000694	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.49e-05	0.000693	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.49e-05	0.000693	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000688	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.46e-05	0.000685	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.43e-05	0.000676	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000675	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.42e-05	0.000671	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.34e-05	0.000649	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.31e-05	0.000641	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.3e-05	0.00064	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.3e-05	0.000639	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.3e-05	0.000638	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.27e-05	0.000632	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000627	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.25e-05	0.000625	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.21e-05	0.000614	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.2e-05	0.00061	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.19e-05	0.000609	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.000609	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.17e-05	0.000602	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.12e-05	0.000589	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.12e-05	0.000589	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.11e-05	0.000588	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.000587	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.09e-05	0.00058	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000577	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000577	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.07e-05	0.000576	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.03e-05	0.000566	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.000561	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000558	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2e-05	0.000555	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.98e-05	0.00055	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	1.98e-05	0.00055	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.98e-05	0.00055	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	1.98e-05	0.00055	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000547	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.96e-05	0.000546	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.94e-05	0.00054	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000511	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.84e-05	0.000511	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.82e-05	0.000506	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000503	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.0005	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.000499	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.78e-05	0.000496	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.000489	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.73e-05	0.00048	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000477	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.7e-05	0.000474	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.00047	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.62e-05	0.000449	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.61e-05	0.000449	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.59e-05	0.000442	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.54e-05	0.000429	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.52e-05	0.000422	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.51e-05	0.000419	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.000417	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.47e-05	0.000409	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.000408	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.4e-05	0.000388	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.38e-05	0.000384	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.38e-05	0.000383	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000369	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	0.000368	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000364	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000363	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000363	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000345	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.22e-05	0.00034	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000333	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.18e-05	0.000328	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.15e-05	0.00032	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000306	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.000301	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000297	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.000297	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.06e-05	0.000296	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.06e-05	0.000295	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.06e-05	0.000295	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000289	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000285	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.97e-06	0.000277	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.84e-06	0.000273	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—NOS3—chronic obstructive pulmonary disease	9.79e-06	0.000272	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.75e-06	0.000271	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.73e-06	0.000271	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.67e-06	0.000269	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.54e-06	0.000265	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.19e-06	0.000256	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.14e-06	0.000254	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.07e-06	0.000252	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.99e-06	0.00025	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	8.89e-06	0.000247	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.45e-06	0.000235	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.27e-06	0.00023	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.01e-06	0.000223	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.01e-06	0.000223	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.71e-06	0.000214	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.5e-06	0.000208	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.39e-06	0.000205	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.33e-06	0.000204	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.05e-06	0.000196	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.89e-06	0.000191	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.86e-06	0.000191	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.59e-06	0.000183	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.53e-06	0.000181	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.38e-06	0.000177	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.68e-06	0.000158	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.62e-06	0.000156	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	5.44e-06	0.000151	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.24e-06	0.000146	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	0.000145	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.13e-06	0.000143	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.86e-06	0.000135	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.8e-06	0.000133	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.72e-06	0.000131	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.48e-06	0.000124	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	4.44e-06	0.000123	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.38e-06	0.000122	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.25e-06	0.000118	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.94e-06	0.00011	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.89e-06	0.000108	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.75e-06	0.000104	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.71e-06	0.000103	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.62e-06	0.000101	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.43e-06	9.54e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.38e-06	9.4e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.37e-06	9.36e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.32e-06	9.23e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.12e-06	8.66e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.09e-06	8.6e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.93e-06	8.15e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.6e-06	7.22e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.56e-06	7.12e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.39e-06	6.64e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.33e-06	6.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-06	6.29e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.23e-06	6.2e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.99e-06	5.54e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	5.3e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-06	4.28e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-06	4.09e-05	CbGpPWpGaD
